Avobenzone CAS NO.70356-09-1

Product description

Product Name:Avobenzone
Product number:BJM-049
CAS:70356-09-1
Molecular formula:C20H22O3
Molecular weight:310.39
Content:99.0%min

Parseal-1789 / CAS No. 70356-09-1  /  Avobenzone / Escalol 517 / UV absorber

Name: Parseal-1789 /  Avobenzone

CAS No: 70356-09-1

Alisa: arseal-1789 ;  Avobenzone ；Escalol 517; Sunscreener 1789 ; Eusolex 9020

MF: C20H22O3

MW: 310.39
Description:white powder 

Density: 1.079 g/cm3
Melting Point: 81-84 °C
 

Avobenzone is an oil soluble ingredient used in sunscreen products to absorb the full spectrum of UVA rays. Its ability to absorb ultraviolet light over a wider range of wavelengths than many organic sunscreen agents has led to its use in many commercial preparations marketed as "broad spectrum" sunscreens. Avobenzone has an absorption maximum of 357 nm.

Usage: Avobenzone  ,  as same sa  UV-531、UV-9、UV-0 and other UVB absorbers ,  it has a good synergy  with very low toxicity, so it's widely used in skin protection products, cosmetics and plastic, resin, paint, UV radiation protection such as synthetic rubber and so on.  In skin care , it can reduce wrinkles, spots, skin problems such as crude,  and can prevent skin cancer.

Wuhan BJM Pharm Inc. was found in 2013, located in Hubei Province, where has long history, rich culture, convenient traffic, beautiful environment and preferential policy.

We have two factories in Dezhou , Shandong and Xianning, Hubei. The factory covers an area of 48,000 square meters with the building area of 26,000 square meters. We are specialized in the manufacture of pharmaceutical intermediates and cosmetic additives with good inspection equipments and innovative R & D capability.

In 2006, We established Lingxian Microworld Chemical New Material Co,.Ltd.

In 2008, We passed ISO quality system certificate

In 2013, We established Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd , and obtain self-operation Import & Export right, mainly responsible for domestic and foreign business. At the same time, we set up R&D lab in Wuhan,Hubei province, can undertake various custom synthesis of intermediates and APIs.

In 2016,  obtain a registered trademark “ BJM ”.

In 2017, we applied for the invention patent of TRIS, and in 2018, we applied for the invention patent of ERDOSTAN intermediate（DL-HOMO）. At present, we have6 patents passed the preliminary examination, and 4 patents are under examination and approval.

In 2019, we purchased a R&D and office building with a total area of 2500 square meters, as our headquarters in Wuhan.

In 2020, we registered BJM Pharm Yunmeng Co., Ltd,  and the new production base settled in Geputan chemical park with  a total area of 50000 square meters.

We are specialized in the R&D ,production and sales of Erdosteine ,Pirfenidone, Telmisartan, Letrozole , Sitagliptin phosphate, Dapagliflozin , Tris , IPTG and related intermediates.

We stick to the principle as: people-oriented, customer first, Hope to establish a win-win business relationship with all friends